Cormorant Asset Management, Lp Top Holdings and 13F Report (2024)

→ Gold Set to EXPLODE! (From Gold Safe Exchange) (Ad)

About Cormorant Asset Management, Lp

Investment Activity

Cormorant Asset Management, Lp has $2.28 billion in total holdings as of March 31, 2024.
Cormorant Asset Management, Lp owns shares of 57 different stocks, but just 25 companies or ETFs make up 80% of its holdings.
Approximately 25.38% of the portfolio was purchased this quarter.
About 22.31% of the portfolio was sold this quarter.
This quarter, Cormorant Asset Management, Lp has purchased 48 new stocks and bought additional shares in 9 stocks.
Cormorant Asset Management, Lp sold shares of 10 stocks and completely divested from 10 stocks this quarter.

Largest Holdings

MoonLake Immunotherapeutics: $426,661,205
EyePoint Pharmaceuticals: $142,483,167
Arcellx: $123,799,000
Alpine Immune Sciences: $107,028,000
BridgeBio Pharma: $99,037,657

Largest New Holdings this Quarter

Corbus Pharmaceuticals: $79,461,000 Holding
NewAmsterdam Pharma: $35,475,000 Holding
CG ONCOLOGY INC: $35,120,000 Holding
Merus: $32,196,450 Holding
HELIX ACQUISITION CORP II: $30,253,600 Holding

Largest Purchases this Quarter

Corbus Pharmaceuticals: 2,025,000 shares (about $79.46M)
PRAXIS PRECISION MEDICINES I: 676,655 shares (about $41.29M)
NewAmsterdam Pharma: 1,500,000 shares (about $35.48M)
CG ONCOLOGY INC: 800,000 shares (about $35.12M)
Merus: 715,000 shares (about $32.20M)

Largest Sales this Quarter

SPYRE THERAPEUTICS INC: 687,080 shares (about $26.06M)
Apellis Pharmaceuticals: 225,000 shares (about $13.23M)
NEUROGENE INC: 207,466 shares (about $10.56M)
Stoke Therapeutics: 660,644 shares (about $8.92M)
BridgeBio Pharma: 141,150 shares (about $4.36M)

Sector Allocation Over Time

Selling

Neutral

Buying

Latest 13F Holdings and Changes Since Previous Quarterly Filing

Issuer Name	Holdings Value	Approximate Purchase/Sale	Change in Shares	Shares Held	% of Portfolio	Sector
MLTX MoonLake Immunotherapeutics	$426,661,205		0.0%	8,494,151	18.7%	Medical
EYPT EyePoint Pharmaceuticals	$142,483,167	$17,672,850 ▲	14.2%	6,893,235	6.3%	Medical
ACLX Arcellx	$123,799,000	$5,564,000 ▲	4.7%	1,780,000	5.4%	Medical
ALPN Alpine Immune Sciences	$107,028,000	$5,946,000 ▲	5.9%	2,700,000	4.7%	Medical
BBIO BridgeBio Pharma	$99,037,657	$4,364,358 ▼	-4.2%	3,203,029	4.3%	Medical
PRAXIS PRECISION MEDICINES I	$79,936,200	$41,289,488 ▲	106.8%	1,310,000	3.5%	COM NEW
CRBP Corbus Pharmaceuticals	$79,461,000	$79,461,000 ▲	New Holding	2,025,000	3.5%	Medical
TARS Tarsus Pharmaceuticals	$77,756,358	$2,992,332 ▼	-3.7%	2,139,102	3.4%	Medical
LBPH Longboard Pharmaceuticals	$72,427,846	$21,600,000 ▲	42.5%	3,353,141	3.2%	Medical
EWTX Edgewise Therapeutics	$54,839,180	$8,290,901 ▲	17.8%	3,006,534	2.4%	Medical
CRNX Crinetics Pharmaceuticals	$53,831,500		0.0%	1,150,000	2.4%	Medical
BMEA Biomea Fusion	$53,384,536		0.0%	3,570,872	2.3%	Medical
KORRO BIO INC	$47,625,300		0.0%	529,170	2.1%	COM
PCVX Vaxcyte	$46,792,350	$1,366,200 ▲	3.0%	685,000	2.1%	Medical
AUTL Autolus Therapeutics	$42,214,335	$7,443,335 ▲	21.4%	6,616,667	1.9%	Medical
PHVS Pharvaris	$39,551,841		0.0%	1,711,460	1.7%	Medical
NAMS NewAmsterdam Pharma	$35,475,000	$35,475,000 ▲	New Holding	1,500,000	1.6%	Medical
CG ONCOLOGY INC	$35,120,000	$35,120,000 ▲	New Holding	800,000	1.5%	COM
ALXO ALX Oncology	$35,034,181		0.0%	3,142,079	1.5%	Medical
BHVN Biohaven	$33,741,706	$29,259,150 ▲	652.7%	616,963	1.5%	Medical
MRUS Merus	$32,196,450	$32,196,450 ▲	New Holding	715,000	1.4%	Medical
AVTE Aerovate Therapeutics	$31,633,868	$4,195,983 ▼	-11.7%	1,069,796	1.4%	Medical
ABIVAX SA	$30,459,000		0.0%	2,130,000	1.3%	SPONSORED ADS
HELIX ACQUISITION CORP II	$30,253,600	$30,253,600 ▲	New Holding	2,909,000	1.3%	CL A ORD SHS
MRNS Marinus Pharmaceuticals	$29,380,000		0.0%	3,250,000	1.3%	Medical
TOURMALINE BIO INC	$28,625,000	$28,625,000 ▲	New Holding	1,250,000	1.3%	COM
JANX Janux Therapeutics	$28,237,500	$28,237,500 ▲	New Holding	750,000	1.2%	Medical
NEUROGENE INC	$27,420,543	$10,560,020 ▼	-27.8%	538,714	1.2%	COM
CARGO THERAPEUTICS INC	$26,394,806		0.0%	1,182,563	1.2%	COM
RYTM Rhythm Pharmaceuticals	$23,831,500		0.0%	550,000	1.0%	Medical
APLS Apellis Pharmaceuticals	$23,512,000	$13,225,500 ▼	-36.0%	400,000	1.0%	Medical
ARQT Arcutis Biotherapeutics	$21,058,750	$21,058,750 ▲	New Holding	2,125,000	0.9%	Medical
IDYA IDEAYA Biosciences	$19,746,000		0.0%	450,000	0.9%	Medical
CABA Cabaletta Bio	$18,766,000	$18,766,000 ▲	New Holding	1,100,000	0.8%	Medical
ATXS Astria Therapeutics	$18,297,500	$18,297,500 ▲	New Holding	1,300,000	0.8%	Medical
ENGENE HOLDINGS INC	$16,950,000	$16,950,000 ▲	New Holding	1,000,000	0.7%	COM
INSM Insmed	$15,599,750		0.0%	575,000	0.7%	Medical
VTYX Ventyx Biosciences	$14,905,000	$14,905,000 ▲	New Holding	2,710,000	0.7%	Medical
NKTX Nkarta	$14,593,500	$14,593,500 ▲	New Holding	1,350,000	0.6%	Medical
SLN Silence Therapeutics	$13,500,000	$13,500,000 ▲	New Holding	625,000	0.6%	Medical
MRSN Mersana Therapeutics	$11,648,000	$11,648,000 ▲	New Holding	2,600,000	0.5%	Medical
CMPX Compass Therapeutics	$11,009,394	$11,009,394 ▲	New Holding	5,560,300	0.5%	Medical
KYVERNA THERAPEUTICS INC	$10,929,600	$10,929,600 ▲	New Holding	440,000	0.5%	COM
BEAM Beam Therapeutics	$9,912,000	$9,912,000 ▲	New Holding	300,000	0.4%	Medical
IMRX Immuneering	$9,523,339	$2,627,273 ▼	-21.6%	3,295,273	0.4%	Medical
SPYRE THERAPEUTICS INC	$9,482,500	$26,060,944 ▼	-73.3%	250,000	0.4%	COM NEW
ARRIVENT BIOPHARMA INC	$9,197,900	$9,197,900 ▲	New Holding	515,000	0.4%	COM
RCKT Rocket Pharmaceuticals	$8,082,000	$4,041,000 ▼	-33.3%	300,000	0.4%	Medical
IRON Disc Medicine	$7,782,500		0.0%	125,000	0.3%	Medical
CNTA Centessa Pharmaceuticals	$6,346,080		0.0%	561,600	0.3%	Medical
GHRS GH Research	$6,321,838		0.0%	593,043	0.3%	Medical
STOK Stoke Therapeutics	$5,766,701	$8,918,695 ▼	-60.7%	427,163	0.3%	Medical
LNTH Lantheus	$4,668,000		0.0%	75,000	0.2%	Medical
VERV Verve Therapeutics	$4,648,000		0.0%	350,000	0.2%	Medical
RAPT RAPT Therapeutics	$4,460,815		0.0%	496,750	0.2%	Medical
VYNE VYNE Therapeutics	$4,280,612		0.0%	1,394,336	0.2%	Medical
BCAB BioAtla	$4,027,793	$35,243 ▼	-0.9%	1,170,870	0.2%	Medical
AMBRX BIOPHARMA INC	$0	$159,929,440 ▼	-100.0%	0	0.0%	COM
RAYZEBIO INC	$0	$75,441,927 ▼	-100.0%	0	0.0%	COM
IMVT Immunovant	$0	$49,081,450 ▼	-100.0%	0	0.0%	Medical
CBAY CymaBay Therapeutics	$0	$42,516,000 ▼	-100.0%	0	0.0%	Medical
OLMA Olema Pharmaceuticals	$0	$34,468,904 ▼	-100.0%	0	0.0%	Medical
SNDX Syndax Pharmaceuticals	$0	$25,391,750 ▼	-100.0%	0	0.0%	Medical
HARPOON THERAPEUTICS INC	$0	$22,550,934 ▼	-100.0%	0	0.0%	COM NEW
AXNX Axonics	$0	$15,557,500 ▼	-100.0%	0	0.0%	Medical
EDIT Editas Medicine	$0	$5,065,000 ▼	-100.0%	0	0.0%	Medical
NEUMORA THERAPEUTICS INC.	$0	$1,573,596 ▼	-100.0%	0	0.0%	COM